What is it about?

Targeting estrogen receptor signaling combined with targeted NO• release represents a promising therapeutic approach in malignant melanoma that has potential to prevent metastatic spread and reduce tumor growth.

Featured Image

Read the Original

This page is a summary of: Therapeutic Potential of Nitric Oxide releasing Selective Estrogen Receptor Modulators (NO-SERMs) in Malignant Melanoma, Journal of Investigative Dermatology, January 2022, Elsevier, DOI: 10.1016/j.jid.2021.12.028.
You can read the full text:

Read

Contributors

The following have contributed to this page